Welcome to LookChem.com Sign In|Join Free

CAS

  • or

152051-61-1

Post Buying Request

152051-61-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

152051-61-1 Usage

Description

H-LYS-ARG-THR-GLY-GLN-TYR-LYS-LEU-OH is a peptide composed of a linear chain of amino acids including lysine, arginine, threonine, glycine, glutamine, tyrosine, lysine, and leucine. It features a free amine group at the N-terminus and a free carboxyl group at the C-terminus, which may contribute to its potential biological activity or function. The sequence's combination of charged, polar, and hydrophobic amino acids suggests it could interact with other molecules or proteins in biological systems.

Uses

Used in Pharmaceutical Industry:
H-LYS-ARG-THR-GLY-GLN-TYR-LYS-LEU-OH is used as a potential therapeutic agent for various applications due to its unique amino acid composition and sequence, which may allow it to interact with specific biological targets or pathways.
Used in Research Applications:
In the field of biological research, H-LYS-ARG-THR-GLY-GLN-TYR-LYS-LEU-OH serves as a valuable tool for studying the interactions between peptides and other biomolecules, as well as for investigating the effects of specific amino acid sequences on biological processes.
Used in Cosmetic Industry:
H-LYS-ARG-THR-GLY-GLN-TYR-LYS-LEU-OH may be utilized in cosmetic formulations for its potential skin-beneficial properties, such as promoting skin hydration, elasticity, or providing antioxidant effects, based on the properties of its constituent amino acids.
Used in Nutritional Supplements:
As a peptide with a specific sequence, H-LYS-ARG-THR-GLY-GLN-TYR-LYS-LEU-OH could be incorporated into nutritional supplements to support muscle growth, recovery, or general health, leveraging the benefits of its constituent amino acids.

Check Digit Verification of cas no

The CAS Registry Mumber 152051-61-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,2,0,5 and 1 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 152051-61:
(8*1)+(7*5)+(6*2)+(5*0)+(4*5)+(3*1)+(2*6)+(1*1)=91
91 % 10 = 1
So 152051-61-1 is a valid CAS Registry Number.

152051-61-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name bFGF (119-126), Basic Fibroblast Growth Factor, human, bovine,KRTGQYKL

1.2 Other means of identification

Product number -
Other names H-LYS-ARG-THR-GLY-GLN-TYR-LYS-LEU-OH

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:152051-61-1 SDS

152051-61-1Upstream product

152051-61-1Downstream Products

152051-61-1Relevant articles and documents

Solid phase method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same

-

Page 12; 13, (2010/02/03)

A solid phase synthesis method for preparing peptide-spacer-lipid conjugates, the peptide-spacer-lipid conjugates synthesized by the method, and liposomes containing the peptide-spacer-lipid conjugates. The present invention provides a convenient solid phase synthesis method for preparing peptide-spacer-lipid conjugates and provides various linkage groups (such as amide group) for conjugating peptide, spacer and lipid, wherein the spacer may comprise PEG. Several advantages can be achieved, such as the synthetic procedure can be simplified, the synthesis process can be set to automation, the purification is easier in each reaction step, and the product losses can be reduced to minimal during synthesis. The present synthesis method is suitable for preparing a wide range of peptide-spacer-lipid conjugates, provides a peptide-spacer-lipid conjugate prepared by the solid phase synthesis method of the present invention, which can be incorporated into a liposome as the targeting moiety for liposomal drug delivery to specific cells, and provides a targeting liposome containing the present peptide-spacer-lipid conjugate.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 152051-61-1